Literature DB >> 11062170

Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation.

Y Takihara1, Y Matsuda, J Hara.   

Abstract

The 14-3-3 proteins are associated with proto-oncogene and oncogene products. Here, we generated NIH 3T3 cells overexpressing the beta isoform of the 14-3-3 proteins (14-3-3 beta) to examine the function of this isoform in cellular proliferation and oncogenic transformation. Overexpression of 14-3-3 beta in NIH 3T3 cells stimulated cell growth and supported anchorage-independent growth in soft agar medium and tumor formation in nude mice. To elucidate the molecular mechanisms of 14-3-3 beta-mediated NIH 3T3 transformation, we examined the activity of mitogen-activated protein kinase (MAPK) after serum stimulation. Overexpression of 14-3-3 beta augmented MAPK activity after serum stimulation, and MAPK activity correlated well with the amount of 14-3-3 beta expression. The colony-forming ability of NIH 3T3 cells overexpressing 14-3-3 beta in soft agar medium was efficiently abolished by exogenous expression of a dominant-negative mutant of MEK1 and 14-3-3 beta physically interacted with Raf-1 in these cells. These findings indicate that 14-3-3 beta has oncogenic potential, mainly through enhancement of Raf-1 activation and resultant augmentation of signaling in the MAPK cascade.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062170     DOI: 10.1093/carcin/21.11.2073

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

Review 1.  14-3-3ζ as a prognostic marker and therapeutic target for cancer.

Authors:  Christopher L Neal; Dihua Yu
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

2.  Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma.

Authors:  Tzu-An Liu; Yee-Jee Jan; Bor-Sheng Ko; Shyh-Chang Chen; Shu-Man Liang; Ya-Lin Hung; Chiun Hsu; Tang-Long Shen; Yen-Ming Lee; Pei-Feng Chen; John Wang; Song-Kun Shyue; Jun-Yang Liou
Journal:  Am J Pathol       Date:  2011-10-01       Impact factor: 4.307

3.  14-3-3β Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway.

Authors:  Sung Bin Seo; Je-Jung Lee; Hye Hyeon Yun; Chang-Nim Im; Yong-Sam Kim; Jeong-Heon Ko; Jeong-Hwa Lee
Journal:  Mol Neurobiol       Date:  2017-01-23       Impact factor: 5.590

4.  Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination.

Authors:  Boris F Krasnikov; Chin-Hsiang Chien; Regina Nostramo; John T Pinto; Edward Nieves; Myrasol Callaway; Jin Sun; Kay Huebner; Arthur J L Cooper
Journal:  Biochimie       Date:  2009-07-10       Impact factor: 4.079

5.  14-3-3β is essential for milk composition stimulated by Leu/IGF-1 via IGF1R signaling pathway in BMECs.

Authors:  Hui Cao; Guan Huang; Haixin Fu; Na Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-06-01       Impact factor: 2.416

6.  Echinococcus multilocularis proliferation in mice and respective parasite 14-3-3 gene expression is mainly controlled by an alphabeta CD4 T-cell-mediated immune response.

Authors:  Wen Juan Dai; Andreas Waldvogel; Mar Siles-Lucas; Bruno Gottstein
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation.

Authors:  Zenggang Li; Jing Zhao; Yuhong Du; Hae Ryoun Park; Shi-Yong Sun; Leon Bernal-Mizrachi; Alastair Aitken; Fadlo R Khuri; Haian Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

8.  Identification of 14-3-3β gene as a novel miR-152 target using a proteome-based approach.

Authors:  Simon Jasinski-Bergner; Franziska Stehle; Evamaria Gonschorek; Jana Kalich; Kristin Schulz; Stefan Huettelmaier; Juliane Braun; Barbara Seliger
Journal:  J Biol Chem       Date:  2014-09-16       Impact factor: 5.157

9.  14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen.

Authors:  Steve A Maxwell; Zenggang Li; David Jaye; David Jaya; Scott Ballard; Jay Ferrell; Haian Fu
Journal:  J Biol Chem       Date:  2009-06-12       Impact factor: 5.157

10.  An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.

Authors:  Mirta M L Sousa; Kamila Anna Zub; Per Arne Aas; Audun Hanssen-Bauer; Aida Demirovic; Antonio Sarno; Erming Tian; Nina B Liabakk; Geir Slupphaug
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.